Table 2 Independent effect of baseline characteristics on odds of adequate visit adherence^a

Male

1.07 (1.01–1.13)

0.033

1.07 (1.01–1.13)

0.029

Age (55–64 is reference group)

 65–74

1.38 (1.30–1.48)

<0.001

1.37 (1.29–1.46)

<0.001

 ≥75

1.34 (1.24–1.46)

<0.001

1.32 (1.22–1.43)

<0.001

Race and Ethnicity (Black is reference group)

 Non-Black Hispanic

0.94 (0.87–1.02)

0.126

0.94 (0.87–1.01)

0.100

 Non-Black Non-Hispanic

1.98 (1.86–2.11)

<0.001

2.00 (1.88–2.13)

<0.001

Education (High school is reference group)

 < High school

0.96 (0.90–1.02)

0.195

 Beyond high school

1.01 (0.94–1.09)

0.741

Has Diabetes

0.92 (0.87–0.98)

0.010

0.92 (0.87–0.98)

0.010

Smoking (Current is ref group)

 Past

1.19 (1.10–1.28)

<0.001

1.19 (1.11–1.29)

<0.001

 Never

1.12 (1.04–1.20)

0.004

1.12 (1.04–1.21)

0.003

Self-assessed baseline health (Excellent is reference group)

 Very good

0.91 (0.80–1.03)

0.137

0.91 (0.80–1.03)

0.131

 Good

0.89 (0.79–1.00)

0.050

0.88 (0.78–1.00)

0.042

 Fair

0.80 (0.70–0.91)

<0.001

0.79 (0.70–0.90)

<0.001

 Poor

0.52 (0.43–0.62)

<0.001

0.51 (0.43–0.61)

<0.001

 Unknown

0.61 (0.42–0.89)

0.010

0.60 (0.41–0.88)

0.009

Practice type (Private is reference group)

 Group

1.23 (1.13–1.33)

<0.001

1.23 (1.14–1.33)

<0.001

 HMO

0.58 (0.51–0.66)

<0.001

0.58 (0.51–0.66)

<0.001

 Community Health Center

1.04 (0.95–1.15)

0.406

1.04 (0.94–1.15)

0.434

 University

1.56 (1.41–1.73)

<0.001

1.56 (1.41–1.72)

<0.001

 Other

1.15 (1.04–1.27)

0.008

1.15 (1.04–1.27)

0.007

 VAMC

2.00 (1.82–2.19)

<0.001

2.00 (1.82–2.20)

<0.001

 Unknown

0.41 (0.37–0.47)

<0.001

0.41 (0.37–0.47)

<0.001

Baseline medications (Untreated is reference group)

 On drug therapy < 2 months

1.41 (1.30–1.54)

<0.001

1.42 (1.30–1.54)

<0.001

 On drug therapy ≥ 2 months

1.10 (0.94–1.28)

0.233

1.10 (0.94–1.28)

0.222

HDL Cholesterol < 35 mg/dl

1.09 (1.00–1.19)

0.052

1.09 (1.00–1.19)

0.048

Taking aspirin

1.20 (1.13–1.27)

<0.001

1.20 (1.13–1.27)

<0.001

Possible disability

2.04 (1.88–2.21)

<0.001

2.03 (1.87–2.20)

<0.001

ASCVD (No ASCVD is reference group)

 Yes

0.90 (0.84–0.97)

0.003

0.90 (0.84–0.96)

0.003

 Sub–clinical

1.03 (0.96–1.11)

0.447

1.03 (0.95–1.11)

0.483

BMI > 30

1.02 (0.97–1.08)

0.453

Decile of clinic enrollment volume

1.03 (1.02–1.04)

<0.001

1.03 (1.02–1.04)

<0.001

Randomized treatment group (Chlorthalidone is reference group)

 Amlodipine

1.01 (0.95–1.07)

0.774

1.01 (0.95–1.07)

0.782

 Lisinopril

0.84 (0.79–0.90)

<0.001

0.84 (0.79–0.90)

<0.001